Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

microLife

Showing results (81-90 of 191) with videos related to

Pageof 20
Sort By:
Microlife|April 4, 2025
Dynamic optimization elucidates higher-level pathogenicity strategies of <i>Pseudomonas aeruginosa</i>Wassili Dimitriew, Stefan Schuster
Microlife|July 12, 2024
Coordinated regulation of osmotic imbalance by c-di-AMP shapes ß-lactam tolerance in Group B <i>Streptococcus</i>Terry Brissac, Cécile Guyonnet, Aymane Sadouni, et al.
Microlife|April 23, 2024
Noncontiguous operon atlas for the <i>Staphylococcus aureus</i> genomePablo Iturbe, Alvaro San Martín, Hiroshi Hamamoto, et al.
Microlife|April 15, 2024
Correction to: Multireceptor phage cocktail against Salmonella enterica to circumvent phage resistance
Microlife|June 24, 2026
Predicted bacterial uRBSs reveal translational coupling and ribosome-mediated RBS occlusion as gene-controlling mechanismsTheresa Dietz, Julian M Hahnfeld, Sophie Neumann, et al.
Microlife|October 13, 2021
Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing modelM Campos, J M Sempere, J C Galán, et al.
Microlife|April 15, 2025
Real-time imaging of bacterial colony growth dynamics for cells with Type IV-A1 CRISPR-Cas activitySelina Rust, Lennart Randau
Microlife|May 27, 2025
Respiratory syncytial virus: health burden, disease prevention, and treatment-recent progress and lessons learnedHarald Brüssow
Microlife|May 16, 2025
Disparate mechanisms counteract extraneous CRISPR RNA production in type II-C CRISPR-Cas systemsMaximilian Feussner, Angela Migur, Alexander Mitrofanov, et al.
Microlife|February 16, 2026
Caspofungin enhances antifungal immunity in human blood through transcriptional reprogrammingAia Shehata, Sascha Schäuble, Ronny Martin, et al.
Pageof 20

Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Microlife|April 4, 2025
Dynamic optimization elucidates higher-level pathogenicity strategies of <i>Pseudomonas aeruginosa</i>Wassili Dimitriew, Stefan Schuster
Microlife|July 12, 2024
Coordinated regulation of osmotic imbalance by c-di-AMP shapes ß-lactam tolerance in Group B <i>Streptococcus</i>Terry Brissac, Cécile Guyonnet, Aymane Sadouni, et al.
Microlife|April 23, 2024
Noncontiguous operon atlas for the <i>Staphylococcus aureus</i> genomePablo Iturbe, Alvaro San Martín, Hiroshi Hamamoto, et al.
Microlife|April 15, 2024
Correction to: Multireceptor phage cocktail against Salmonella enterica to circumvent phage resistance
Microlife|June 24, 2026
Predicted bacterial uRBSs reveal translational coupling and ribosome-mediated RBS occlusion as gene-controlling mechanismsTheresa Dietz, Julian M Hahnfeld, Sophie Neumann, et al.
Microlife|October 13, 2021
Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing modelM Campos, J M Sempere, J C Galán, et al.
Microlife|April 15, 2025
Real-time imaging of bacterial colony growth dynamics for cells with Type IV-A1 CRISPR-Cas activitySelina Rust, Lennart Randau
Microlife|May 27, 2025
Respiratory syncytial virus: health burden, disease prevention, and treatment-recent progress and lessons learnedHarald Brüssow
Microlife|May 16, 2025
Disparate mechanisms counteract extraneous CRISPR RNA production in type II-C CRISPR-Cas systemsMaximilian Feussner, Angela Migur, Alexander Mitrofanov, et al.
Microlife|February 16, 2026
Caspofungin enhances antifungal immunity in human blood through transcriptional reprogrammingAia Shehata, Sascha Schäuble, Ronny Martin, et al.
Pageof 20